Patents Assigned to Morphochem GmbH
  • Oxazolidinone-quinolone hybrid antibacterial for the parenteral treatment of prophylaxis of bacterial diseases
    Patent number: 11261205
    Abstract: The present invention relates to the use of oxazolidinone-quinolone hybrids for the parenteral (especially intravenous) treatment or prophylaxis of bacterial diseases. The present invention relates moreover to improved methods of administering oxazolidinone-quinolone hybrid antibacterials.
    Type: Grant
    Filed: June 22, 2020
    Date of Patent: March 1, 2022
    Assignee: Morphochem GmbH
    Inventors: Thomas Kapsner, Axel Dalhoff, Thomas Gramatte